ELI LILLY & Co (LLY)
Every FINRA and SEC series the site collects for ELI LILLY & Co: short interest with days to cover, daily short sale volume, fails to deliver and Form 4 insider trades. Listed on NYSE, classified by the SEC as pharmaceutical preparations.
6.6M
Short interest
settlement 2026-08-14
2.1
Days to cover
-28.0% vs prior
38.2%
Short share of volume
2026-09-11
2,681
Fails to deliver
settlement 2026-08-14
-$16.0M
Insider flow, 90 days
0 buys, 3 sells
As of 2026-09-11.
Short interest
FINRA, twice a month; the last 12 months shown, all 48 settlements in the JSONAs of 14 August 2026, short interest in LLY is 6,564,742 shares, down 3,714,150 shares over the last month. Over the last 48 readings it ranged from 5,786,764 shares (15 October 2024) to 10,278,892 shares (15 July 2026). At the reported average volume of 3.1M shares a day that is 2.1 days to cover.
Embed this chartfree, with the attribution line it carries
<iframe src="https://xoomar.com/embed/stocks/lly" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-08-14 | 6,564,742 | -28.0% | 3,106,628 | 2.11 |
| 2026-07-31 | 9,117,184 | -11.3% | 2,316,357 | 3.94 |
| 2026-07-15 | 10,278,892 | +9.9% | 2,527,511 | 4.07 |
| 2026-06-30 | 9,353,153 | -3.2% | 3,624,842 | 2.58 |
| 2026-06-15 | 9,662,739 | -1.4% | 3,211,646 | 3.01 |
| 2026-05-29 | 9,795,475 | +16.2% | 3,307,630 | 2.96 |
| 2026-05-15 | 8,430,505 | +7.2% | 3,326,719 | 2.53 |
| 2026-04-30 | 7,862,175 | -3.1% | 3,521,025 | 2.23 |
| 2026-04-15 | 8,114,678 | +5.3% | 2,842,565 | 2.85 |
| 2026-03-31 | 7,704,068 | +12.1% | 3,131,283 | 2.46 |
| 2026-03-13 | 6,873,427 | +1.3% | 2,454,629 | 2.80 |
| 2026-02-27 | 6,785,689 | +6.4% | 3,184,626 | 2.13 |
| 2026-02-13 | 6,379,120 | -8.6% | 4,384,383 | 1.45 |
| 2026-01-30 | 6,981,558 | -9.3% | 2,879,996 | 2.42 |
| 2026-01-15 | 7,697,492 | +10.4% | 3,028,579 | 2.54 |
| 2025-12-31 | 6,970,774 | +6.5% | 2,605,596 | 2.68 |
| 2025-12-15 | 6,547,749 | -7.4% | 3,383,572 | 1.94 |
| 2025-11-28 | 7,073,265 | -2.4% | 3,847,630 | 1.84 |
| 2025-11-14 | 7,247,713 | +12.6% | 5,244,081 | 1.38 |
| 2025-10-31 | 6,436,275 | -6.0% | 3,138,460 | 2.05 |
| 2025-10-15 | 6,843,231 | -11.0% | 3,718,380 | 1.84 |
| 2025-09-30 | 7,686,850 | +5.0% | 4,007,818 | 1.92 |
| 2025-09-15 | 7,323,001 | -8.9% | 2,901,226 | 2.52 |
| 2025-08-29 | 8,041,246 | -7.5% | 4,250,575 | 1.89 |
Daily short volume
FINRA Reg SHO, last 60 sessions. JSONAs of 11 September 2026, the short share of LLY volume is 38.2%, up 1.5 points over the last five sessions. Over the last 52 readings it ranged from 32.5% (9 July 2026) to 58.1% (16 July 2026). The latest reading is 4.1 points below the 30-session average of 42.3%, on 635K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-09-11 | 242K | 635K | 38.2% | 172 |
| 2026-09-10 | 343K | 713K | 48.1% | 17 |
| 2026-09-09 | 329K | 713K | 46.1% | 786 |
| 2026-09-08 | 385K | 882K | 43.7% | 428 |
| 2026-09-04 | 306K | 684K | 44.8% | 250 |
| 2026-09-03 | 284K | 773K | 36.7% | 1,957 |
| 2026-09-02 | 333K | 1.0M | 33.1% | 7,025 |
| 2026-09-01 | 427K | 899K | 47.5% | 2,896 |
| 2026-08-31 | 390K | 961K | 40.6% | 2,731 |
| 2026-08-28 | 356K | 781K | 45.6% | 1,578 |
| 2026-08-27 | 407K | 893K | 45.6% | 175 |
| 2026-08-26 | 506K | 1.2M | 41.1% | 968 |
| 2026-08-25 | 273K | 795K | 34.4% | 899 |
| 2026-08-24 | 300K | 637K | 47.1% | 516 |
| 2026-08-21 | 434K | 852K | 50.9% | 1,104 |
| 2026-08-20 | 402K | 876K | 45.9% | 52 |
| 2026-08-19 | 849K | 1.9M | 44.4% | 149 |
| 2026-08-18 | 375K | 846K | 44.4% | 1,105 |
| 2026-08-17 | 261K | 630K | 41.4% | 796 |
| 2026-08-14 | 418K | 841K | 49.7% | 152 |
| 2026-08-13 | 416K | 769K | 54.1% | 272 |
| 2026-08-12 | 336K | 854K | 39.3% | 859 |
| 2026-08-11 | 318K | 866K | 36.7% | 873 |
| 2026-08-10 | 444K | 1.1M | 40.5% | 4,323 |
| 2026-08-07 | 321K | 900K | 35.7% | 1,580 |
| 2026-08-06 | 452K | 1.2M | 39.0% | 299 |
| 2026-08-05 | 1.2M | 2.7M | 43.5% | 255 |
| 2026-08-04 | 537K | 1.5M | 36.2% | 893 |
| 2026-08-03 | 461K | 1.2M | 39.8% | 1,688 |
| 2026-07-31 | 369K | 1.1M | 33.6% | 1,991 |
Fails to deliver
SEC, by settlement date. JSONAs of 14 August 2026, the fails-to-deliver balance in LLY is 2,681 shares, up 2,265 shares over the last settlement date. Over the last 52 readings it ranged from 2 shares (5 June 2026) to 27,324 shares (4 June 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-08-14 | 2,681 | $1209.00 | $3.2M |
| 2026-08-12 | 416 | $1215.02 | $505K |
| 2026-08-11 | 193 | $1231.94 | $238K |
| 2026-08-10 | 8,965 | $1185.71 | $10.6M |
| 2026-08-07 | 270 | $1191.94 | $322K |
| 2026-08-06 | 270 | $1169.86 | $316K |
| 2026-07-30 | 821 | $1210.02 | $993K |
| 2026-07-29 | 984 | $1220.66 | $1.2M |
| 2026-07-27 | 259 | $1196.03 | $310K |
| 2026-07-20 | 2,581 | $1179.11 | $3.0M |
| 2026-07-15 | 338 | $1152.54 | $390K |
| 2026-07-10 | 40 | $1216.95 | $49K |
| 2026-07-09 | 155 | $1215.83 | $188K |
| 2026-07-07 | 1,890 | $1200.06 | $2.3M |
| 2026-06-29 | 12,307 | $1208.12 | $14.9M |
| 2026-06-23 | 855 | $1102.08 | $942K |
| 2026-06-17 | 2,051 | $1122.50 | $2.3M |
| 2026-06-15 | 3,499 | $1133.00 | $4.0M |
| 2026-06-11 | 490 | $1136.37 | $557K |
| 2026-06-08 | 113 | $1131.42 | $128K |
| 2026-06-05 | 2 | $1125.27 | $2K |
| 2026-06-04 | 27,324 | $1078.78 | $29.5M |
| 2026-06-01 | 1,119 | $1105.00 | $1.2M |
| 2026-04-20 | 16,403 | $927.03 | $15.2M |
| 2026-04-17 | 13,384 | $903.99 | $12.1M |
| 2026-04-15 | 6 | $922.50 | $6K |
| 2026-04-14 | 28 | $929.55 | $26K |
| 2026-04-09 | 76 | $953.30 | $72K |
| 2026-04-01 | 4 | $919.77 | $4K |
| 2026-03-25 | 179 | $903.02 | $162K |
Insider trades
SEC Form 4, newest first, 50 of 100 shown. JSONInsiders at LLY reported 3 open-market sells worth $16.0M in the last 90 days and no open-market buys. Sells alone are a weak signal; insiders sell for tax, diversification and estate reasons all the time. Latest filing: Seymour Melissa (EVP, Global Quality) on 2026-09-09.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-09-09 | Seymour Melissa | EVP, Global Quality | Gift | 12 | $0.00 | $0 | 1K |
| 2026-08-17 | Jonsson Patrik | EVP & President, LLY Int'l | Sell | 7K | $1175.10 | $7.6M | 54K |
| 2026-08-17 | Sulzberger Gabrielle | n/a | Grant | 4 | $1183.16 | $5K | 3K |
| 2026-08-17 | LUCIANO JUAN R | n/a | Grant | 13 | $1183.16 | $16K | 17K |
| 2026-08-17 | Fyrwald J Erik | n/a | Grant | 8 | $1183.16 | $10K | 75K |
| 2026-08-17 | Alvarez Ralph | n/a | Grant | 10 | $1183.16 | $12K | 56K |
| 2026-08-10 | Zakrowski Donald A | SVP, Finance, & CAO | Sell | 2K | $1185.01 | $2.4M | 2K |
| 2026-08-07 | Hakim Anat | EVP, GC & Secretary | Sell | 5K | $1190.00 | $6.0M | 12K |
| 2026-08-01 | Seymour Melissa | EVP, Global Quality | Tax withholding | 439 | $1148.84 | $504K | 1K |
| 2026-08-01 | Seymour Melissa | EVP, Global Quality | Option exercise | 981 | $0.00 | $0 | 2K |
| 2026-07-20 | Sulzberger Gabrielle | n/a | Grant | 4 | $1146.90 | $5K | 3K |
| 2026-07-20 | LUCIANO JUAN R | n/a | Grant | 14 | $1146.90 | $16K | 17K |
| 2026-07-20 | Fyrwald J Erik | n/a | Grant | 9 | $1146.90 | $10K | 75K |
| 2026-07-20 | Alvarez Ralph | n/a | Grant | 11 | $1146.90 | $12K | 56K |
| 2026-06-15 | Alvarez Ralph | n/a | Grant | 11 | $1129.35 | $12K | 56K |
| 2026-06-10 | Yuffa Ilya | EVP&Pres, LLY USA&Global Capab | Sell | 3K | $1150.77 | $2.9M | 30K |
| 2026-05-18 | Sulzberger Gabrielle | n/a | Grant | 5 | $988.09 | $5K | 3K |
| 2026-05-18 | LUCIANO JUAN R | n/a | Grant | 16 | $988.09 | $16K | 17K |
| 2026-05-18 | Fyrwald J Erik | n/a | Grant | 10 | $988.09 | $10K | 75K |
| 2026-05-18 | Alvarez Ralph | n/a | Grant | 13 | $988.09 | $12K | 56K |
| 2026-05-06 | LILLY ENDOWMENT INC | n/a | Sell | 2K | $996.18 | $2.2M | 91.9M |
| 2026-05-06 | LILLY ENDOWMENT INC | n/a | Sell | 14K | $995.23 | $13.6M | 91.9M |
| 2026-04-20 | Sulzberger Gabrielle | n/a | Grant | 5 | $919.90 | $5K | 3K |
| 2026-04-20 | LUCIANO JUAN R | n/a | Grant | 17 | $919.90 | $16K | 17K |
| 2026-04-20 | Fyrwald J Erik | n/a | Grant | 11 | $919.90 | $10K | 75K |
| 2026-04-20 | Alvarez Ralph | n/a | Grant | 13 | $919.90 | $12K | 56K |
| 2026-03-16 | Sulzberger Gabrielle | n/a | Grant | 5 | $989.12 | $5K | 3K |
| 2026-03-16 | LUCIANO JUAN R | n/a | Grant | 16 | $989.12 | $16K | 17K |
| 2026-03-16 | Fyrwald J Erik | n/a | Grant | 10 | $989.12 | $10K | 75K |
| 2026-03-16 | Alvarez Ralph | n/a | Grant | 13 | $989.12 | $12K | 56K |
| 2026-02-19 | Dozier Eric | EVP, Chief People Officer | Gift | 481 | $0.00 | $0 | 14K |
| 2026-02-17 | Sulzberger Gabrielle | n/a | Grant | 5 | $1036.05 | $5K | 3K |
| 2026-02-17 | LUCIANO JUAN R | n/a | Grant | 15 | $1036.05 | $16K | 17K |
| 2026-02-17 | Fyrwald J Erik | n/a | Grant | 10 | $1036.05 | $10K | 75K |
| 2026-02-17 | Alvarez Ralph | n/a | Grant | 12 | $1036.05 | $12K | 55K |
| 2026-02-16 | Montarce Lucas | EVP & CFO | Tax withholding | 160 | $1040.00 | $166K | 16K |
| 2026-02-16 | Montarce Lucas | EVP & CFO | Option exercise | 368 | $0.00 | $0 | 16K |
| 2026-02-16 | Zakrowski Donald A | SVP, Finance, & CAO | Tax withholding | 82 | $1040.00 | $85K | 4K |
| 2026-02-16 | Zakrowski Donald A | SVP, Finance, & CAO | Option exercise | 184 | $0.00 | $0 | 4K |
| 2026-02-16 | Custer Kenneth L. | EVP & President, Card Met Hlth | Tax withholding | 91 | $1040.00 | $95K | 10K |
| 2026-02-16 | Custer Kenneth L. | EVP & President, Card Met Hlth | Option exercise | 207 | $0.00 | $0 | 10K |
| 2026-02-16 | Brown Adrienne S | EVP, President LLY Imm | Tax withholding | 170 | $1040.00 | $177K | 5K |
| 2026-02-16 | Brown Adrienne S | EVP, President LLY Imm | Option exercise | 391 | $0.00 | $0 | 5K |
| 2026-02-09 | Hernandez Edgardo | EVP & Pres., Mfg. Operations | Grant | 4K | $1044.67 | $4.6M | 46K |
| 2026-02-09 | Rau Diogo | EVP & CIDO | Grant | 4K | $1044.67 | $4.6M | 26K |
| 2026-02-09 | Yuffa Ilya | EVP&Pres, LLY USA&Global Capab | Grant | 4K | $1044.67 | $4.3M | 32K |
| 2026-02-09 | Jonsson Patrik | EVP & President, LLY Int'l | Grant | 5K | $1044.67 | $5.0M | 61K |
| 2026-02-09 | Montarce Lucas | EVP & CFO | Grant | 1K | $1044.67 | $1.4M | 16K |
| 2026-02-09 | Skovronsky Daniel | EVP, CS&PO & Pres. LRL | Grant | 16K | $1044.67 | $16.2M | 160K |
| 2026-02-09 | Hakim Anat | EVP, GC & Secretary | Grant | 8K | $1044.67 | $8.6M | 23K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are the rarer, stronger signal.
Planned sales (Form 144)
Newest first. JSON2 Form 144 notices on file for LLY worth $14.3M at the prices reported; 2 in the last 90 days worth $14.3M. Latest: DONALD ZAKROWSKI filed on 2026-08-10 to sell 2,000 shares ($2.4M) from 2026-08-10.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-08-10 | DONALD ZAKROWSKIOfficer | 2K | $2.4M | 0.000% | 2026-08-10 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-07 | Hakim AnatOfficer | 10K | $11.9M | 0.001% | 2026-08-07 | THE CHARLES SCHWAB CORPORATION |
13F holders
Tracked managers holding LLY at their latest 13F. JSON12 of the 30 tracked managers held LLY at their latest 13F, $16.09B in total at quarter-end prices. Citadel Advisors is the largest at $6.21B (0.7% of its portfolio) as of 2026-06-30. Over the prior quarter 5 added shares and 5 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Citadel Advisors | 2026-06-30 | 5.2M | $6.21B | 0.71% | +1.6M |
| Fisher Asset Management | 2026-06-30 | 5.1M | $6.07B | 1.81% | new or n/a |
| AQR Capital Management | 2026-06-30 | 1.0M | $1.24B | 0.43% | +180K |
| D. E. Shaw & Co. | 2026-06-30 | 924K | $1.11B | 0.53% | -244K |
| Millennium Management | 2026-06-30 | 780K | $935.4M | 0.34% | -128K |
| Two Sigma Investments | 2026-06-30 | 132K | $158.0M | 0.11% | +58K |
| Bridgewater Associates | 2026-06-30 | 87K | $104.4M | 0.43% | +16K |
| ARK Investment Management | 2026-06-30 | 77K | $92.7M | 0.60% | +65K |
| Point72 Asset Management | 2026-06-30 | 77K | $92.2M | 0.10% | -81K |
| Renaissance Technologies | 2026-06-30 | 26K | $31.3M | 0.04% | -46K |
| Soros Fund Management | 2026-06-30 | 22K | $26.6M | 0.33% | 0 |
| Duquesne Family Office | 2026-06-30 | 12K | $14.8M | 0.28% | -88K |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
Financials
SEC XBRL, as filed. JSONIn Q2 2026 (quarter ended 2026-06-30) ELI LILLY & Co reported revenue of $22.97B, up 47.7% from the same quarter a year earlier, and net income of $7.09B (7.94 diluted EPS). In FY 2025 it generated $16.81B of operating cash flow and spent $4.11B on buybacks and $5.38B on dividends. As of 2026-06-30, cash was $8.95B against $54.91B of debt.
- Cash
- $8.95B
- Debt
- $54.91B
- Equity
- $33.88B
- Total assets
- $142.28B
- Shares outstanding
- 941,357,065
Quarterly, last 8 quarters
| Quarter | Period end | Revenue | Net income | Margin | Diluted EPS |
|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $22.97B | $7.09B | 30.9% | 7.94 |
| Q1 2026 | 2026-03-31 | $19.80B | $7.40B | 37.4% | 8.26 |
| Q4 2025derived | 2025-12-31 | $19.29B | $6.64B | 34.4% | n/a |
| Q3 2025 | 2025-09-30 | $17.60B | $5.58B | 31.7% | 6.21 |
| Q2 2025 | 2025-06-30 | $15.56B | $5.66B | 36.4% | 6.29 |
| Q1 2025 | 2025-03-31 | $12.73B | $2.76B | 21.7% | 3.06 |
| Q4 2024derived | 2024-12-31 | $13.53B | $4.41B | 32.6% | n/a |
| Q3 2024 | 2024-09-30 | $11.44B | $970.3M | 8.5% | 1.07 |
Fiscal years, with buybacks and dividends
| Fiscal year | Ends | Revenue | Net income | Operating cash flow | Capex | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $65.18B | $20.64B | $16.81B | n/a | $4.11B | $5.38B |
| FY 2024 | 2024-12-31 | $45.04B | $10.59B | $8.82B | n/a | $2.50B | $4.68B |
| FY 2023 | 2023-12-31 | $34.12B | $5.24B | $4.24B | n/a | $750.0M | $4.07B |
| FY 2022 | 2022-12-31 | $28.54B | $6.24B | $7.59B | n/a | $1.50B | $3.54B |
| FY 2021 | 2021-12-31 | $28.32B | $5.58B | $7.37B | n/a | $1.25B | $3.09B |
Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are cash paid to repurchase common stock in the year (XBRL PaymentsForRepurchaseOfCommonStock), not authorizations. Balance sheet lines are as of 2026-06-30; shares outstanding as of 2026-08-03 from the cover page.
What this page is
ELI LILLY & Co in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page pulls every series the site collects for one ticker onto one URL, keyed by the SEC's own ticker list, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a summary sentence built from the rows (last value, change, range with dates) and its own JSON and CSV links. Nothing on the page is written by a model; the sentences change only when the data does. A page exists only for companies with data in at least two series, and every section says when its source last updated.
This page follows ELI LILLY & Co (LLY), SEC CIK 59478, listed on NYSE, classified by the SEC as pharmaceutical preparations. The cross-market tables live on the short interest and insider transactions hubs.
Source and method
- Short interest
- FINRA consolidated short interestTwice a month, about eight business days after settlement. Latest 2026-08-14.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesEvery trading day, loaded the following morning. Latest 2026-09-11.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataTwice a month, a few weeks after the half month ends. Latest 2026-08-14.JSON and CSV
- Planned sales
- SEC EDGAR Form 144EDGAR read every 30 minutes; a notice is filed on or before the sell order. Latest 2026-08-10.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRQuarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Financials
- SEC XBRL company factsRefreshed weekly from the SEC's structured data; values are as filed in the 10-Q and 10-K. Latest 2026-06-30.JSON and CSV
- Insider trades
- SEC EDGAR Form 4EDGAR read every 30 minutes; filings are due two business days after the trade. Latest 2026-09-09.JSON and CSV
- Company record
- EDGAR filing index for CIK 59478Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 30 requests a minute without a key, 120 a minute with a key from a free account.
Data checks. Every dataset is checked against its source once a day. This dataset passed the last run, 13 Sep 05:40 UTC.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a crowded short are the combination that has historically preceded squeezes; insider sells next to a crowded short are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as pharmaceutical preparations
- UTHRUNITED THERAPEUTICS Corp
- CPIXCUMBERLAND PHARMACEUTICALS INC
- ALNYALNYLAM PHARMACEUTICALS, INC.
- PTCTPTC THERAPEUTICS, INC.
- MDGLMADRIGAL PHARMACEUTICALS, INC.
- ONCBeOne Medicines Ltd.
- IONSIONIS PHARMACEUTICALS INC
- INSMINSMED Inc
- CORTCORCEPT THERAPEUTICS INC
- BBIOBridgeBio Pharma, Inc.
- ROIVRoivant Sciences Ltd.
- CYTKCYTOKINETICS INC
- VRTXVERTEX PHARMACEUTICALS INC / MA
- LGNDLIGAND PHARMACEUTICALS INC
- SIONSionna Therapeutics, Inc.
- LQDALiquidia Corp
- BLTEBELITE BIO, INC
- TVTXTravere Therapeutics, Inc.
- PAHCPHIBRO ANIMAL HEALTH CORP
- ARQTArcutis Biotherapeutics, Inc.
- HOWLWerewolf Therapeutics, Inc.
- NATRNATURES SUNSHINE PRODUCTS INC
- JNJJOHNSON & JOHNSON
- BMYBRISTOL MYERS SQUIBB CO
Datasets
Frequently Asked Questions
How much of LLY is sold short?
What is LLY's daily short volume?
Does LLY have fails to deliver?
Are LLY insiders buying or selling?
Have LLY insiders filed to sell?
What did LLY report last quarter?
Which funds hold LLY?
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.